The number of either CD8+ (CD45RA+CD103+) or CD4+ (CD45RA+PTK7+) RTEs was not significantly different in PD patients compared to controls (p = 0.512 and p = 0.111, respectively) (Fig. 3A, B). This evidence concerns the gene CD8A and Parkinson disease.